Inflammatics Inc is categorized under Noncommercial Biotechnical Research in West Chester, PA and active since 1995.
Inflammatics Inc was established in 1995, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Noncommercial Biotechnical Research business, which does work in the B2B market, and is classified as a Noncommercial Biotechnical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Nigel John Smart at the company’s single location by writing to 401 Chrislena Lane, West Chester, Pennsylvania PA 19380 or by phoning (610) 692-1665. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Inflammatics Inc |
| Contact Person: | Nigel John Smart |
| Address: | 401 Chrislena Lane, West Chester, Pennsylvania 19380 |
| Phone Number: | (610) 692-1665 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1995 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Noncommercial Biotechnical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Inflammatics Inc was started in 1995 to provide professional Noncommercial Biotechnical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Nigel John Smart for inquiries that concern Inflammatics Inc by calling the company number (610) 692-1665, as your correspondence is most welcome. Additionally, the physical location of the single location of Inflammatics Inc can be found at the coordinates 39.973958,-75.622745 as well as the street address 401 Chrislena Lane in West Chester, Pennsylvania 19380.
For its online presence, you may visit Inflammatics Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.